Exelixis Inc/ US30161Q1040 /
29/05/2024 22:00:00 | Var. +0.1500 | Volume | Denaro01:58:29 | Lettera01:58:29 | Max | Min |
---|---|---|---|---|---|---|
20.4900USD | +0.74% | 1.87 mill. Fatturato: 27.76 mill. |
20.2000Quantità in denaro: 200 | 20.6000Quantità in lettera: 500 | 20.5950 | 20.1400 |
GlobeNewswire
09:42
Bayer and Burning Rock collaborate to increase patient access to precision cancer medicines
GlobeNewswire
09:01
Persistent Systems Selects Zscaler to Launch Technology Modernization and Renewable Energy Initiativ...
GlobeNewswire
09:00
Curium Announces First Commercial Doses in France of Pylclari® – an Innovative 18F-Psma Pet Tracer I...
GlobeNewswire
09:00
Green Bioactives Reports Remarkable Cognitive Benefits of its Newly Launched Memory-boosting Nutrace...
GlobeNewswire
08:35
Nxera Pharma to Receive $4.6 Million in Milestone Payments from Centessa Pharmaceuticals
GlobeNewswire
08:30
Samsung Bioepis to Present Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimi...
GlobeNewswire
08:30
BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’...
GlobeNewswire
08:30
Nxera Pharma and PrecisionLife Expand Strategic R&D Partnership into New Therapeutic Area